The Bulletin cover image

Would I Lie to You?

The Bulletin

CHAPTER

The Impact of Medications on Obesity and Health

Exploring the rise of Novo Nordisk and Eli Lilly shares due to Ozempic success, a weight loss medication. Discussion on the medical benefits of GLP1 agonists, their impact on health issues linked to obesity, and the implications of severe obesity. Delving into the complexities of how Christians perceive medication use for weight loss, the debate on health benefits versus financial costs, and concerns about over-medication in society.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner